Open the mobile version, with barcode scanning
Class III Terminated

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd.

Why: Subpotent Drug.

Company
Teva Pharmaceuticals USA
North Wales, PA, United States
Reported
Mar 27, 2019
Recall started
Mar 11, 2019
Ended
Nov 15, 2019
Where sold
Nationwide in the United States.
Amount
7,081 bottles
Full product description
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93
Lots / codes affected
Lot #: 25Q002, Exp. 11/2019

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.